Floatz logo

Monomethyl Fumarate

B Cell Leukemia

Wondercel Biotech (ShenZhen)Small moleculeEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the B Cell Leukemia cohort.

Asset / SponsorPhaseRating
CD19-CAR-T2 Cells
Nanfang Hospital, Southern Medical University
Phase 2B
Cart-19 And 20 Cells
University of Pennsylvania
Phase 1/2CCC
Autologous 3Rd Generation Cd19-Targeting Car T Cells
Uppsala University
Phase 1/2CCC
Tisagenlecleucel
iCell Gene Therapeutics
Phase 1CCC
Car-Itnk Cells
Nanfang Hospital, Southern Medical University
Phase 1/2CCC

View all 23 →

Same molecule, other indications

Monomethyl Fumarate is also rated in:

Blood Stem Cell Transplant FailureDormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi AnemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Refractory Anemia With Excess BlastsDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →